Skip to main content
SpringerLink
Log in

P 792

(Vistarem™)

  • Research Review
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Notes

  1. 1This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

References

  1. Gaillard S, Kubiak C, Stolz C, Bonnemain B, Chassard D. Safety and pharmacokinetics of P792, a new blood-pool agent — results of clinical testing in nonpatient volunteers. Investigative Radiology. 37: 161–166, Apr 2002

    Article  PubMed  CAS  Google Scholar 

  2. Rühm SG, Corot C, Treiber K, Debatin JF. MR-angiography with a new intravascular contrast agent (P 792): assessment in rabbits. 13th European Congress of Radiology.: abstr. B-0512, 2 Mar 2001

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

P 792. Drugs R&D 3, 305 (2002). https://doi.org/10.2165/00126839-200203050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200203050-00003

Keywords

Search

Navigation